Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
PEGS Boston SummitPEGS Boston Summit
Not Confirmed
Not Confirmed
11 May-15 November, 2026
Pharmex Middle EastPharmex Middle East
Not Confirmed
Not Confirmed
26-28 May, 2026
Not Confirmed
Not Confirmed
27-28 May, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
PEGS Boston SummitPEGS Boston Summit
Industry Trade Show
Not Confirmed
11 May-15 November, 2026
Pharmex Middle EastPharmex Middle East
Industry Trade Show
Not Confirmed
26-28 May, 2026
Industry Trade Show
Not Confirmed
27-28 May, 2026
Digital content

23 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/23/3224417/0/en/Bavarian-Nordic-Signs-Distribution-Agreement-with-Eurofarma-to-Expand-Access-to-Chikungunya-Vaccine-in-Brazil.html

21 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sk-biopharmaceuticals-launches-joint-venture-with-eurofarma-for-ai-based-epilepsy-management-platform-302589583.html
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Through the licensing deal, a Chikungunya Vaccine, Recombinant will be developed to address the key focus area of chikungunya.
Lead Product(s): Chikungunya Vaccine, Recombinant
Therapeutic Area: Infections and Infectious Diseases Brand Name: Vimkunya
Study Phase: Approved FDFProduct Type: Vaccine
Recipient: Bavarian Nordic
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement January 23, 2026

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Chikungunya Vaccine, Recombinant
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Recipient : Bavarian Nordic
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Bavarian Nordic Signs Distribution Deal with Eurofarma for Chikungunya Vaccine in Brazil
Details : Through the licensing deal, a Chikungunya Vaccine, Recombinant will be developed to address the key focus area of chikungunya.
Product Name : Vimkunya
Product Type : Vaccine
Upfront Cash : Undisclosed
January 23, 2026

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Xcopri (cenobamate), is an antiseizure medication (ASM) for adults with partial-onset (focal) seizures, is now approved as oral suspension or can be administered via a nasogastric tube.
Lead Product(s): Cenobamate
Therapeutic Area: Neurology Brand Name: Xcopri
Study Phase: Approved FDFProduct Type: Controlled Substance
Sponsor: SK Biopharmaceuticals
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable October 08, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cenobamate
Therapeutic Area : Neurology
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : SK Biopharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
SK Biopharm and Eurofarma Submit NDA for Epilepsy Drug in Brazil
Details : Xcopri (cenobamate), is an antiseizure medication (ASM) for adults with partial-onset (focal) seizures, is now approved as oral suspension or can be administered via a nasogastric tube.
Product Name : Xcopri
Product Type : Controlled Substance
Upfront Cash : Inapplicable
October 08, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Eurofarma will have the exclusive rights to develop and sell K-CAB in Brazil. HK inno.N will transfer its technology of manufacturing the treatment to the Brazilian company.
Lead Product(s): Tegoprazan
Therapeutic Area: Gastroenterology Brand Name: K-CAB
Study Phase: Approved FDFProduct Type: Miscellaneous
Recipient: HK inno.N
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Licensing Agreement January 26, 2023

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Tegoprazan
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Recipient : HK inno.N
Deal Size : Undisclosed
Deal Type : Licensing Agreement
HK inno.N Signs Deal with Eurofarma for K-CAB Tablets
Details : Eurofarma will have the exclusive rights to develop and sell K-CAB in Brazil. HK inno.N will transfer its technology of manufacturing the treatment to the Brazilian company.
Product Name : K-CAB
Product Type : Miscellaneous
Upfront Cash : Undisclosed
January 26, 2023

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
AMPICILLIN SODIUM; SULBACTAM SODIUM
Dosage Form : INJECTABLE;INJECTION
Brand Name : AMPICILLIN AND SULBACTAM
Dosage Strength : EQ 1GM BASE/VIAL;EQ 50...
Packaging :
Approval Date : 2007-06-29
Application Number : 65316
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : DISCN
Registration Country : USA
AMPICILLIN SODIUM; SULBACTAM SODIUM
Dosage Form : INJECTABLE;INJECTION
Brand Name : AMPICILLIN AND SULBACTAM
Dosage Strength : EQ 2GM BASE/VIAL;EQ 1G...
Packaging :
Approval Date : 2007-06-29
Application Number : 65316
Regulatory Info : DISCN
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION/DROPS;OPHTHALMI...
Brand Name : BETAXOLOL HYDROCHLORIDE
Dosage Strength : EQ 0.5% BASE
Packaging :
Approval Date : 2001-04-12
Application Number : 75630
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : CREAM;TOPICAL
Brand Name : LOPROX
Dosage Strength : 0.77%
Packaging :
Approval Date : 1982-12-30
Application Number : 18748
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : SUSPENSION;TOPICAL
Brand Name : LOPROX
Dosage Strength : 0.77%
Packaging :
Approval Date : 1988-12-30
Application Number : 19824
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : CREAM;TOPICAL
Brand Name : SYNALAR
Dosage Strength : 0.025%
Packaging :
Approval Date : 1982-01-01
Application Number : 12787
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : CREAM;TOPICAL
Brand Name : SYNALAR
Dosage Strength : 0.01%
Packaging :
Approval Date : 1982-01-01
Application Number : 12787
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : CREAM;TOPICAL
Brand Name : SYNALAR
Dosage Strength : 0.025%
Packaging :
Approval Date : 1982-01-01
Application Number : 12787
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : OINTMENT;TOPICAL
Brand Name : SYNALAR
Dosage Strength : 0.025%
Packaging :
Approval Date : 1982-01-01
Application Number : 13960
Regulatory Info : RX
Registration Country : USA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : RX
Registration Country : USA
Dosage Form : SOLUTION;TOPICAL
Brand Name : SYNALAR
Dosage Strength : 0.01%
Packaging :
Approval Date : 1982-01-01
Application Number : 15296
Regulatory Info : RX
Registration Country : USA

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
AMPICILLIN SODIUM; SULBACTAM SODIUM
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : AMPICILLIN AND SULBACTAM
Dosage Strength : EQ 1GM BASE/VIAL;EQ 500M...
Approval Date : 2007-06-29
Application Number : 65316
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
AMPICILLIN SODIUM; SULBACTAM SODIUM
Dosage Form : INJECTABLE; INJECTION
Proprietary Name : AMPICILLIN AND SULBACTAM
Dosage Strength : EQ 2GM BASE/VIAL;EQ 1GM ...
Approval Date : 2007-06-29
Application Number : 65316
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AT
Dosage Form : SOLUTION/DROPS; OPHTHALMIC
Proprietary Name : BETAXOLOL HYDROCHLORIDE
Dosage Strength : EQ 0.5% BASE
Approval Date : 2001-04-12
Application Number : 75630
RX/OTC/DISCN : RX
RLD : No
TE Code : AT

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AB
Dosage Form : CREAM; TOPICAL
Proprietary Name : LOPROX
Dosage Strength : 0.77%
Approval Date : 1982-12-30
Application Number : 18748
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AB
Dosage Form : SUSPENSION; TOPICAL
Proprietary Name : LOPROX
Dosage Strength : 0.77%
Approval Date : 1988-12-30
Application Number : 19824
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AT
Dosage Form : CREAM; TOPICAL
Proprietary Name : SYNALAR
Dosage Strength : 0.025%
Approval Date : 1982-01-01
Application Number : 12787
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AT

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AT
Dosage Form : CREAM; TOPICAL
Proprietary Name : SYNALAR
Dosage Strength : 0.01%
Approval Date : 1982-01-01
Application Number : 12787
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AT

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AT
Dosage Form : CREAM; TOPICAL
Proprietary Name : SYNALAR
Dosage Strength : 0.025%
Approval Date : 1982-01-01
Application Number : 12787
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AT

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AT
Dosage Form : OINTMENT; TOPICAL
Proprietary Name : SYNALAR
Dosage Strength : 0.025%
Approval Date : 1982-01-01
Application Number : 13960
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AT

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AT
Dosage Form : SOLUTION; TOPICAL
Proprietary Name : SYNALAR
Dosage Strength : 0.01%
Approval Date : 1982-01-01
Application Number : 15296
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AT

REF. STANDARDS & IMPURITIES
CAS Number :
Details :
Monograph : PHR2660-250MG
Quantity Per Vial :
Sale Unit :
Price : $335.00
Storage : +2?C to +8?C
Code/Batch No :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE